2331 - 2340 of 6258 Results
Title
Year
- A double-hit in vivo model of GBA viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degeneration2022OPENTitle: A double-hit in vivo model of GBA viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degenerationJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 163Issue #:Start Page: 105612End Page: 105612Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105612Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105612Citation Count: 5
- BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's Disease2021OPENTitle: BDNF rs6265 Genotype Influences Outcomes of Pharmacotherapy and Subthalamic Nucleus Deep Brain Stimulation in Early-Stage Parkinson's DiseaseJournal Name: Neuromodulation: Technology at the Neural InterfacePublisher: Elsevier BVVol: 25Issue #: 6Start Page: 846End Page: 853Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1111/ner.13504Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8770717Citation Count: 9
-
OPENTitle: Cytosolic sequestration of spatacsin by Protein Kinase A and 14-3-3 proteinsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 174Issue #:Start Page: 105858End Page: 105858Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105858Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105858Citation Count: 5
- Spontaneous changes in brain striatal dopamine synthesis and storage dynamics ex vivo reveal end-product feedback-inhibition of tyrosine hydroxylase2022OPENTitle: Spontaneous changes in brain striatal dopamine synthesis and storage dynamics ex vivo reveal end-product feedback-inhibition of tyrosine hydroxylaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 212Issue #:Start Page: 109058End Page: 109058Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109058Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109058Citation Count: 8
-
OPENTitle: Anxiety in Parkinson's disease: A resting-state high density EEG studyJournal Name: Neurophysiologie CliniquePublisher: Elsevier BVVol: 52Issue #: 3Start Page: 202End Page: 211Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.neucli.2022.01.001Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S0987705322000016?via%3DihubCitation Count: 17
- Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse model2022OPENTitle: Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse modelJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 218Issue #:Start Page: 109213End Page: 109213Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109213Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109213Citation Count: 8
-
OPENTitle: Special Issue on new therapeutic approaches to Parkinson diseaseJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 208Issue #:Start Page: 108998End Page: 108998Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.108998Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.108998Citation Count: 4
-
OPENTitle: Preserved motor memory in Parkinson's diseaseJournal Name: NeuropsychologiaPublisher: Elsevier BVVol: 167Issue #:Start Page: 108161End Page: 108161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropsychologia.2022.108161Best OA location URL: https://doi.org/10.1101/2021.04.30.441882Citation Count: 13
- Necessity and feasibility of remote tele-programming of deep brain stimulation systems in Parkinson's disease2022OPENTitle: Necessity and feasibility of remote tele-programming of deep brain stimulation systems in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 38End Page: 42Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.017Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.01.017Citation Count: 25
- Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studies2022OPENTitle: Immediate-release/extended-release amantadine (OS320) to treat Parkinson's disease with levodopa-induced dyskinesia: Analysis of the randomized, controlled ALLAY-LID studiesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 96Issue #:Start Page: 65End Page: 73Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.01.022Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.01.022Citation Count: 18